NCITA are delighted to attend and exhibit at “Translational Research at Manchester 2022” on the 16th November 2022. This event will focus on how researchers can‘progress their translational research with the support of the Translation Manchester Research Network (TMRN) and will highlight the impact that TMRN partners have had on previous translational research to showcase the importance of multidisciplinary collaborations.
Click here to view the TMRN eBooklet, which includes details about NCITA’s infrastructure support for multicentre clinical imaging biomarker research.
Visit our NCITA trade stand (number 24) in the Pendulum Suite at the “Translational Research at Manchester 2022” event to find out more about NCITA’s infrastructure support which is available to clinical researchers (academic and commercial) for the delivery of early and late phase clinical imaging biomarker studies. Click here to view the full programme for the event.
NCITA is a UK-wide integrated infrastructure that aims to deliver standardised, quality assured imaging biomarkers for clinical use. Our NCITA infrastructure support includes a specialised clinical imaging trials unit, a quality assurance and quality control unit and data repository services. This provides researchers with a unified infrastructure to conduct multi-centre clinical imaging research. To find out more about NCITA and our study adoption process which is open to clinical researchers in academia and industry, view our NCITA brochure at: https://ncita.org.uk/ncita-brochure